Designer Babies: Examining the Ethics of Genetic Testing
By Tracy Lowe,
Parentology [cites CGS' Katie Hasson]
| 06. 21. 2023
If you could choose the healthiest embryo to carry so that your future child could avoid deadly diseases, would you do it? Would you choose an embryo that is more likely to be happy and less likely to have mental health problems like depression and schizophrenia? What about choosing your child’s athletic abilities or IQ?
If you could hand-pick all of your child’s physical, mental, and emotional traits before getting pregnant, where would you draw the line?
This scenario that used to only exist in science fiction is already partially a reality with a company called Genomic Prediction offering something that they call an “Embryo Health Score” or PGT-P test, which allows people to test their embryos to see which are more at risk of certain diseases like heart disease, cancer, diabetes, and schizophrenia. Future parents can then “compare overall disease risks among embryos and make decisions about which embryo to prioritize for transfer.”
Despite The American College of Medical Genetics saying “preimplantation PRS testing is not yet appropriate for clinical use and should not be offered at this time,”...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...